Knowles Corporation (NYSE:KN) Q1 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals a mixed but generally positive outlook. Financial performance is stable with strong cash flow and debt reduction, despite slight revenue decline and margin pressure. Optimistic guidance for Q2 and beyond, along with strategic customer commitments, suggests future growth. Share repurchase and debt reduction enhance shareholder value. The Q&A indicates potential market share gains and improved margins. Tariff impacts are minimal, and customer demand remains solid. Overall, these factors suggest a potential positive stock price movement over the next two weeks.
Key Financial Performance
Revenue $132 million, down 1% year-over-year; at the high end of the guided range.
EPS $0.18, flat year-over-year; at the midpoint of the guided range.
Medtech and Specialty Audio Revenue $60 million, up slightly year-over-year; seasonally down from Q4.
Precision Device Revenue $73 million, down 2% year-over-year; expected due to production challenges.
Gross Margins 48.7%, down 450 basis points year-over-year; impacted by supply agreement with Syntient and unfavorable customer mix.
SG&A Expenses $25 million, down $2 million year-over-year; driven by cost reduction actions.
Interest Expense $3 million, down $2 million year-over-year; due to reduced debt level.
Cash from Operations $1 million, exceeding the high end of the guided range; driven by higher than expected customer prepayments.
Capital Spending $4 million; reflects ongoing investments.
Debt Reduction $15 million; reflects strong cash generation.
Cash Balance $102 million; reflects strong cash generation.
Net Leverage Ratio 0.7 times; indicates manageable debt levels.
Liquidity Excess of $350 million; includes cash on hand and unused capacity under revolving credit facility.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Product Developments: We continue to see strong design wins across our product portfolio, particularly in medtech, defense, and EV markets with our ceramic capacitors.
Market Expansion: Our backlog for the medtech and specialty audio segment for Q2 is strong, indicating continued innovative solutions and enhancing performance in these markets.
Booking Trends: Q1 booking trends for the Precision Device segment were strong for the second consecutive quarter, with broad-based strength across most end markets.
Operational Efficiencies: We are making progress in our specialty film line production, with a new prototype production line improving production flow and yields.
Cash Generation: We generated $1 million in cash from operating activities, exceeding the high end of our guided range.
Strategic Shifts: We expect to explore acquisition opportunities, buy back shares, and maintain manageable debt levels as we generate robust cash from operations throughout 2025.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Tariff Exposure: Knowles Corporation faces direct tariff exposure, with less than 5% of revenue potentially subject to tariffs. The company believes it can pass these costs onto customers without significant loss of business.
Indirect Tariff Impact: The company estimates that less than 3% of its cost of goods sold will be affected by tariffs, and anticipates recovering most of these costs through price increases.
Customer Demand Impact: The impact of tariffs on customer demand is uncertain. However, Knowles believes that its markets in medtech, defense, and industrial sectors will be relatively insulated from these impacts.
Production Challenges: Knowles is experiencing production challenges in its specialty film line, which could affect revenue growth in the Precision Device segment.
Economic Sensitivity: The industrial market is more sensitive to economic downturns, and while there is currently no impact on demand, the company is closely monitoring the macroeconomic environment.
Gross Margin Decline: Gross margins have declined due to unfavorable customer mix and a supply agreement with Syntient, which negatively impacted margins by nearly 200 basis points.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Proximity Manufacturing Strategy: Less than 5% of revenue is subject to current tariffs due to proximity manufacturing, allowing for potential recovery of tariff impacts through price increases.
Growth in Medtech and Specialty Audio: Expectations of year-over-year revenue growth accelerating in Q2 2025, driven by strong backlog and innovative solutions.
Precision Device Segment: Strong design and quoting activity in medtech, defense, and EV markets, with expectations of year-over-year growth returning in Q2 2025.
Share Repurchase and Debt Reduction: In Q1, $5 million in shares were repurchased and $15 million in debt was reduced, with plans for continued cash generation and potential acquisitions.
Investor Day: Scheduled for May 13, 2025, to discuss future growth plans and competitive advantages.
Q2 Revenue Guidance: Expected revenue between $135 million and $145 million.
Q2 EPS Guidance: Projected EPS range of $0.21 to $0.25 per share.
Q2 EBIT Margin Guidance: Adjusted EBIT margin projected between 19% to 21%.
Full-Year Capital Spending: Expected to be 5% of revenues, increasing investments for capacity expansion.
Cash Generation Guidance: Projected cash from operations between $10 million and $20 million.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase: In the first quarter, we purchased $5 million in shares.
Debt Reduction: We reduced our debt level by $15 million.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are you hearing from your customers in this uncertain time around their outlooks and how it may impact you in the back half of this year?
A:We’ve not seen any change in demand. Expectations for Q2 are incrementally higher than they were a quarter ago. Most of our products are custom and essential devices, especially in medtech and defense. We do have some exposure in industrial, but inventory levels are normalizing, leading to increased order activity.
Q:Any updates on the $75 million plus capacitor order starting next year into an energy end market?
A:We received a substantial prepayment in Q1, and the customer is fully committed. We don’t see any impact on delivery starting in 2026, expecting about $25 million of shipments on this order in 2026.
Q:Can you talk about gross margin trajectory starting Q2 and where you think it ends up in Q4?
A:We expect significant sequential improvement in gross margins, driven by increased demand and capacity utilization. We anticipate gross margins to exit the year in the range of 45% to 47%.
Q:Do you think you might be able to pick up share from some of your competitors that don’t produce much in the US?
A:I’m hesitant to say yet, but we are getting calls from customers considering buying from us due to tariffs and supply security, primarily in the industrial space.
Q:Can you add some commentary around bookings and the increase in receivables?
A:Bookings were above 1.15, and inventory at distributors is decreasing, leading to more orders. Receivables are up due to timing of customer collections, not collection issues.
Q:What’s next for Knowles Corporation in terms of organic and inorganic growth opportunities?
A:We will discuss organic opportunities at the Investor Day. On the inorganic side, our head of corporate development will present, and while the market is cautious on M&A, we are ready for the right opportunity.
Q:Review of Unclear Management Responses
A:Management appeared to avoid giving a direct answer when asked about the potential to pick up market share from competitors, using vague language about being hesitant to make predictions. Additionally, there was a lack of clarity regarding the specifics of the inorganic growth opportunities, with management indicating that they would provide more details at the Investor Day.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Asia
COVID market
Miss maam
Transcript inline
activity medtech
audio basis
backlog medtech
basis health
bubble burst
burst crisis
capacitor trend
com
confidence
day Miss
debt level
expectation day
experience
film line
inline expectation
market capacitor
market medtech
medtech defense
medtech specialty
proximity
ramp
recession
segment solution
share debt
specialty audio
specialty film
supply
tariff environment
tariff exposure
tariff impact
tariff market
tariff situation
KN Transcript
Knowles Corporation (KN) Q4 2025 Earnings Call Transcript
Positive2-5
Despite some concerns about management's lack of clarity on gross margin guidance, the overall sentiment is positive. The company reported strong financial performance, with significant revenue growth in key segments and optimistic guidance for 2025. The Q&A session highlighted promising organic growth opportunities and strong demand across various markets. The company's strategic initiatives and operational efficiencies are expected to drive further growth, supporting a positive stock price movement in the short term.
Knowles Corporation (KN) Q3 2025 Earnings Call Transcript
Positive10-23
The earnings call highlights strong revenue growth, improved gross margins, and strategic expansion in specialty films, with optimistic guidance for MedTech and Precision Devices. While there are some uncertainties in M&A timelines and industrial segment growth, the overall sentiment remains positive due to high demand, operational improvements, and robust bookings. The Q&A session reinforced confidence in future growth and margin improvements, leading to a positive outlook for stock price movement.
Knowles Corporation (KN) Q2 2025 Earnings Call Transcript
Positive7-24
The company reported strong financial performance with an 8% revenue increase and a 20% EPS rise. While SG&A expenses increased, the company maintained manageable debt levels and reduced interest expenses. Share repurchases of $30 million reflect confidence in cash flow. Positive guidance and strong bookings further support a positive outlook. Despite some margin pressures, the overall sentiment is positive, especially with expected margin improvements and continued revenue growth.
Knowles Corporation (NYSE:KN) Q1 2025 Earnings Call Transcript
Positive4-26
The earnings call reveals a mixed but generally positive outlook. Financial performance is stable with strong cash flow and debt reduction, despite slight revenue decline and margin pressure. Optimistic guidance for Q2 and beyond, along with strategic customer commitments, suggests future growth. Share repurchase and debt reduction enhance shareholder value. The Q&A indicates potential market share gains and improved margins. Tariff impacts are minimal, and customer demand remains solid. Overall, these factors suggest a potential positive stock price movement over the next two weeks.
KN Slides
KN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
